Accessibility Menu
 
Proteomics International Laboratories logo

Proteomics International Laboratories

(ASX) PIQ

Current Price$0.25
Market Cap$41.30M
Since IPO (2015)+11%
5 Year-78%
1 Year-34%
1 Month-14%

Proteomics International Laboratories Financials at a Glance

Market Cap

$41.30M

Revenue (TTM)

$3.98M

Net Income (TTM)

$16.77M

EPS (TTM)

$-0.06

P/E Ratio

-3.97

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$0.25

Volume

98,835

Open

$0.24

Previous Close

$0.25

Daily Range

$0.24 - $0.26

52-Week Range

$0.20 - $0.86

PIQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Proteomics International Laboratories

Industry

Life Sciences Tools and Services

CEO

Richard Lipscombe, PhD

Headquarters

Perth, WA 6009, AU

PIQ Financials

Key Financial Metrics (TTM)

Gross Margin

-19%

Operating Margin

-26%

Net Income Margin

-20%

Return on Equity

-150%

Return on Capital

-1%

Return on Assets

-85%

Earnings Yield

-25.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.30M

Shares Outstanding

165.18M

Volume

98.83K

Avg. Volume

363.81K

Financials (TTM)

Gross Profit

$960.39K

Operating Income

$10.62M

EBITDA

$10.00M

Operating Cash Flow

$6.60M

Capital Expenditure

$29.65K

Free Cash Flow

$6.63M

Cash & ST Invst.

$11.04M

Total Debt

$277.74K

Proteomics International Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$357.44K

-34.0%

Gross Profit

$5.00M

-58.8%

Gross Margin

-14.00%

N/A

Market Cap

$41.30M

N/A

Market Cap/Employee

$1.12M

N/A

Employees

37

N/A

Net Income

$6.03M

-60.6%

EBITDA

$6.18M

-71.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$6.99M

+41.9%

Accounts Receivable

$221.22K

+664.4%

Inventory

$0.00

N/A

Long Term Debt

$454.34K

+4037.9%

Short Term Debt

$227.11K

+541.4%

Return on Assets

-85.45%

N/A

Return on Invested Capital

-1.39%

N/A

Free Cash Flow

$3.01M

-75.5%

Operating Cash Flow

$950.22K

+28.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RAD.AXRadiopharm Theranostics Limited
$0.02+0.00%
NSB.AXNeuroScientific Biopharmaceuticals Limited
$0.10+0.00%
CSX.AXCleanSpace Holdings Limited
$0.42-3.45%
ADO.AXAnteoTech Limited
$0.01+10.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$99.62+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About PIQ

What is the current price of Proteomics International Laboratories?

Proteomics International Laboratories is trading at A$0.25 per share.

What is the 52-week range for Proteomics International Laboratories?

Over the past 52 weeks, Proteomics International Laboratories has traded between A$0.21 and A$0.86.

How much debt does Proteomics International Laboratories have?

As of the most recent reporting period, Proteomics International Laboratories reported total debt of $277,739.

How much cash does Proteomics International Laboratories have on hand?

Proteomics International Laboratories reported $11.04M in cash and cash equivalents in its most recent financial results.

What is Proteomics International Laboratories’s dividend yield?

Proteomics International Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.